Klaus Junker
Overview
Explore the profile of Klaus Junker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rustemeyer J, Busch A, Junker K
J Maxillofac Oral Surg
. 2024 Feb;
23(1):210-218.
PMID: 38312958
Background: Although the uncommon dentinogenic ghost cell tumour (DGCT) is a benign entity, it possesses the ability to cause widespread destruction of the jaws and to recur after bone-preserving therapy....
2.
Schutte W, Gutz S, Nehls W, Blum T, Bruckl W, Buttmann-Schweiger N, et al.
Pneumologie
. 2023 Oct;
77(10):671-813.
PMID: 37884003
The current S3 Lung Cancer Guidelines are edited with fundamental changes to the previous edition based on the dynamic influx of information to this field:The recommendations include de novo a...
3.
Kamp J, Neubert L, Ackermann M, Stark H, Werlein C, Fuge J, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163504
(1) Background: In COVID-19 survivors there is an increased prevalence of pulmonary fibrosis of which the underlying molecular mechanisms are poorly understood; (2) Methods: In this multicentric study, n =...
4.
Johrens K, Fischer J, Mobs M, Junker K, Kirfel J, Perner S, et al.
Pathologe
. 2021 Nov;
43(2):126-134.
PMID: 34807276
Round robin testing is an important instrument for quality assurance. Increasingly, this also applies to the results of molecular diagnostics in pathology, which directly influence therapy decisions in precision oncology....
5.
Gambichler T, Abu Rached N, Tannapfel A, Becker J, Vogt M, Skrygan M, et al.
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34063983
We aimed to assess for the first time the mismatch repair (MMR) protein expression in Merkel cell carcinoma (MCC). Immunohistochemistry was performed for MLH1, MSH2, MSH6, and PMS2 on patients'...
6.
Rustemeyer J, Gunther L, Junker K, Thieme V, Busch A, Okcu Y, et al.
J Maxillofac Oral Surg
. 2021 Apr;
20(2):219-226.
PMID: 33927488
Background: Melanotic neuroectodermal tumour of infancy (MNTI) is a rare benign neoplasm. MNTI appears most often during the first year of life, arises predominantly in the maxilla and tends to...
7.
Kriegsmann M, Casadonte R, Maurer N, Stoehr C, Erlmeier F, Moch H, et al.
J Cancer
. 2020 Sep;
11(20):6081-6089.
PMID: 32922548
While subtyping of the majority of malignant chromophobe renal cell carcinoma (cRCC) and benign renal oncocytoma (rO) is possible on morphology alone, additional histochemical, immunohistochemical or molecular investigations are required...
8.
Belge G, Hennig F, Dumlupinar C, Grobelny F, Junker K, Radtke A, et al.
Oncotarget
. 2020 May;
11(16):1462-1473.
PMID: 32363003
Serum levels of microRNA-371a-3p represent a specific tumor marker of testicular germ cell tumors (GCTs) but the origin of circulating miR-371a-3p is not finally resolved. The correlation between miR-levels in...
9.
Lueken N, Kaune K, Junker K, Zutt M
J Dtsch Dermatol Ges
. 2018 Nov;
16(11):1387-1390.
PMID: 30395392
No abstract available.
10.
Lueken N, Kaune K, Junker K, Zutt M
J Dtsch Dermatol Ges
. 2018 Sep;
16(11):1387-1390.
PMID: 30204943
No abstract available.